Insider transactions

EDGAR

Rocket Pharmaceuticals, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-22.

Open-market purchases (code P)
1 transactions, 10,000 shares
Sum of shares × price per share: 34,400
Open-market sales (code S)
27 transactions, 314,752 shares
Sum of shares × price per share: 990,983.949

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 74

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-11-18 Filed 2026-11-20Shah Gaurav Officer: CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,2162.178
4,826.448

Derived: shares × price per share. Exact value 4826.448.

1,051,358Direct (D) No
F1, F2
  • F1 Holdings include Restricted Stock Units (RSUs) that convert to common stock on a one-for-one basis.
  • F2 The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
Open filing 0001140361-26-045110 Read from the filing’s XML Dispute this row
2026-11-18 Filed 2026-11-20Wilson Martin Officer: General Counsel
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)6772.178
1,474.506

Derived: shares × price per share. Exact value 1474.506.

540,336Direct (D) No
F1, F2
  • F1 Holdings include Restricted Stock Units (RSUs) that convert to common stock on a one-for-one basis.
  • F2 The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
Open filing 0001140361-26-045108 Read from the filing’s XML Dispute this row
2026-11-13 Filed 2026-11-17Shah Gaurav Officer: CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)3,0202.250
6,795

Derived: shares × price per share. Exact value 6795.000.

1,053,574Direct (D) No
F1, F2
  • F1 Holdings include Restricted Stock Units (RSUs) that convert to common stock on a one-for-one basis.
  • F2 The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
Open filing 0001140361-26-044546 Read from the filing’s XML Dispute this row
2026-11-13 Filed 2026-11-17Wilson Martin Officer: General Counsel
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)4,0872.25
9,195.75

Derived: shares × price per share. Exact value 9195.75.

541,013Direct (D) No
F1, F2
  • F1 Holdings include Restricted Stock Units (RSUs) that convert to common stock on a one-for-one basis.
  • F2 The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
Open filing 0001140361-26-044544 Read from the filing’s XML Dispute this row
2026-11-09 Filed 2026-11-12Chaudhuri Sarbani Officer: See Remarks
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)4,8722.327
11,337.144

Derived: shares × price per share. Exact value 11337.144.

257,937Direct (D) No
F1, F2
  • F1 Holdings include Restricted Stock Units (RSUs) that convert to common stock on a one-for-one basis.
  • F2 The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
Open filing 0001140361-26-043480 Read from the filing’s XML Dispute this row
2026-11-05 Filed 2026-11-09Wilson Martin Officer: General Counsel
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)53,3892.394
127,813.266

Derived: shares × price per share. Exact value 127813.266.

545,100Direct (D) No
F1, F2
  • F1 Holdings include Restricted Stock Units (RSUs) that convert to common stock on a one-for-one basis.
  • F2 The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
Open filing 0001140361-26-042784 Read from the filing’s XML Dispute this row
2026-09-11 Filed 2026-09-15Wilson Martin Officer: General Counsel
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)75,3643.403
256,463.692

Derived: shares × price per share. Exact value 256463.692.

598,489Direct (D) No
F1, F2
  • F1 Holdings include Restricted Stock Units (RSUs) that convert to common stock on a one-for-one basis.
  • F2 The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
Open filing 0001140361-26-036688 Read from the filing’s XML Dispute this row
2026-08-18 Filed 2026-08-20Wilson Martin Officer: General Counsel
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)6313.381
2,133.411

Derived: shares × price per share. Exact value 2133.411.

673,853Direct (D) No
F1, F2
  • F1 Holdings include Restricted Stock Units (RSUs) that convert to common stock on a one-for-one basis.
  • F2 The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
Open filing 0001140361-26-033915 Read from the filing’s XML Dispute this row
2026-08-18 Filed 2026-08-20Shah Gaurav Officer: CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,2933.381
7,752.633

Derived: shares × price per share. Exact value 7752.633.

1,056,594Direct (D) No
F1, F2
  • F1 Holdings include Restricted Stock Units (RSUs) that convert to common stock on a one-for-one basis.
  • F2 The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
Open filing 0001140361-26-033913 Read from the filing’s XML Dispute this row
2026-08-13 Filed 2026-08-17Shah Gaurav Officer: CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,8373.381
9,591.897

Derived: shares × price per share. Exact value 9591.897.

1,058,887Direct (D) No
F1, F2
  • F1 Holdings include Restricted Stock Units (RSUs) that convert to common stock on a one-for-one basis.
  • F2 The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
Open filing 0001140361-26-033417 Read from the filing’s XML Dispute this row
2026-08-13 Filed 2026-08-17Wilson Martin Officer: General Counsel
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)3,4933.381
11,809.833

Derived: shares × price per share. Exact value 11809.833.

674,484Direct (D) No
F1, F2
  • F1 Holdings include Restricted Stock Units (RSUs) that convert to common stock on a one-for-one basis.
  • F2 The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
Open filing 0001140361-26-033413 Read from the filing’s XML Dispute this row
2026-08-11 Filed 2026-08-13Stevens Christopher James Officer: Chief Operating Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)36,6583.499
128,266.342

Derived: shares × price per share. Exact value 128266.342.

505,784Direct (D) No
F1, F2
  • F1 Holdings include Restricted Stock Units (RSUs) that convert to common stock on a one-for-one basis.
  • F2 The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
Open filing 0001140361-26-032818 Read from the filing’s XML Dispute this row
2026-08-11 Filed 2026-08-13Chaudhuri Sarbani Officer: See Remarks
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)4,7013.499
16,448.799

Derived: shares × price per share. Exact value 16448.799.

262,809Direct (D) No
F1, F2
  • F1 Holdings include Restricted Stock Units (RSUs) that convert to common stock on a one-for-one basis.
  • F2 The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
Open filing 0001140361-26-032816 Read from the filing’s XML Dispute this row
2026-08-03 Filed 2026-08-05Stevens Christopher James Officer: Chief Operating Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)73,3130—542,442Direct (D) No
F1, F2
  • F1 Holdings include Restricted Stock Units (RSUs) that convert to common stock on a one-for-one basis.
  • F2 Represents RSUs, one-third (1/3) of which will become fully vested on August 3, 2027, with the remaining shares vesting in equal quarterly installments over the following two years.
Open filing 0001140361-26-031473 Read from the filing’s XML Dispute this row
2026-08-03 Filed 2026-08-05Stevens Christopher James Officer: Chief Operating Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (101,428) — exercise price 3.41
Acquired (A)101,4280—101,428Direct (D) No
F3
  • F3 This option represents a right to purchase a total of 101,428 shares of the Issuer's common stock, one-third of which will become fully vested and exercisable on August 3, 2027, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.
Open filing 0001140361-26-031473 Read from the filing’s XML Dispute this row
2026-08-03 Filed 2026-08-05SOUTHWELL DAVID P Director
J

Other acquisition or disposition (describe transaction)

Common Stock
Acquired (A)150,0000—204,522Direct (D) No
F1, F2
  • F1 Rocket Pharmaceuticals, Inc. (the Company) entered into a consulting agreement with the Reporting Person, dated July 21, 2026, for consulting services related to the Company's strategic and financial activities. As compensation for services rendered, the Reporting Person received 150,000 restricted stock units (RSUs) on August 3, 2026.
  • F2 Represents RSUs that convert to common stock on a one-for-one basis. One-third of such RSUs will vest in full on August 3, 2027, with the remaining two-thirds vesting in equal quarterly installments over the following two years.
Open filing 0001140361-26-031471 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-07-06Dolsten Mikael Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)22,8620—67,082Direct (D) No
F1, F2
  • F1 Represents restricted stock units (RSUs) that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2027.
  • F2 This option represents a right to purchase a total of 64,860 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 18, 2027.
Open filing 0001140361-26-027679 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-07-06Dolsten Mikael Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (64,860) — exercise price 3.35
Acquired (A)64,8600—64,860Direct (D) No
F2
  • F2 This option represents a right to purchase a total of 64,860 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 18, 2027.
Open filing 0001140361-26-027679 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-07-06BOESS CARSTEN Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)22,8620—52,862Direct (D) No
F1
  • F1 Represents restricted stock units (RSUs) that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2027.
Open filing 0001140361-26-027676 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-07-06BOESS CARSTEN Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (64,860) — exercise price 3.35
Acquired (A)64,8600—64,860Direct (D) No
F2
  • F2 This option represents a right to purchase a total of 64,860 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 18, 2027.
Open filing 0001140361-26-027676 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-07-06Malik Fady Ibraham Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)22,8620—52,862Direct (D) No
F1
  • F1 Represents restricted stock units (RSUs) that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2027.
Open filing 0001140361-26-027678 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-07-06Malik Fady Ibraham Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (64,860) — exercise price 3.35
Acquired (A)64,8600—64,860Direct (D) No
F2
  • F2 This option represents a right to purchase a total of 64,860 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 18, 2027.
Open filing 0001140361-26-027678 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-07-06Fong Peter Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)22,8620—76,195Direct (D) No
F1, F2
  • F1 Represents restricted stock units (RSUs) that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2027.
  • F2 This option represents a right to purchase a total of 64,860 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 18, 2027.
Open filing 0001140361-26-027680 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-07-06Fong Peter Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (64,860) — exercise price 3.35
Acquired (A)64,8600—64,860Direct (D) No
F2
  • F2 This option represents a right to purchase a total of 64,860 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 18, 2027.
Open filing 0001140361-26-027680 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-07-06SOUTHWELL DAVID P Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)22,8620—54,522Direct (D) No
F1
  • F1 Represents restricted stock units (RSUs) that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2027.
Open filing 0001140361-26-027677 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-07-06SOUTHWELL DAVID P Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (64,860) — exercise price 3.35
Acquired (A)64,8600—64,860Direct (D) No
F2
  • F2 This option represents a right to purchase a total of 64,860 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 18, 2027.
Open filing 0001140361-26-027677 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-07-06WONG RODERICK Director · 10% owner
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)27,8320—75,499Direct (D) No
F1
  • F1 Represents restricted stock units (RSUs) that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2027.
Open filing 0001140361-26-027681 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-07-06WONG RODERICK Director · 10% owner
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (78,960) — exercise price 3.35
Acquired (A)78,9600—78,960Direct (D) No
F3
  • F3 This option represents a right to purchase a total of 78,960 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 18, 2027.
Open filing 0001140361-26-027681 Read from the filing’s XML Dispute this row
2026-05-26 Filed 2026-05-28Militello John Officer: See Remarks
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (10,000) — exercise price 18.75
Disposed (D)10,000——0Direct (D) No
F1, F2
  • F1 On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026.
  • F2 This option represents a right to purchase a total of 10,000 shares of the Issuer's Common Stock, 3,336 of which will become fully vested and exercisable on March 29, 2019, with the remaining 6,664 shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.
Open filing 0001140361-26-023153 Read from the filing’s XML Dispute this row
2026-05-26 Filed 2026-05-28Militello John Officer: See Remarks
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (10,000) — exercise price 20.61
Disposed (D)10,000——0Direct (D) No
F1, F3
  • F1 On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026.
  • F3 This option represents a right to purchase a total of 10,000 shares of the Issuer's Common Stock, 3,336 of which will become fully vested and exercisable on June 25, 2019, with the remaining 6,664 shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.
Open filing 0001140361-26-023153 Read from the filing’s XML Dispute this row
2026-05-26 Filed 2026-05-28Militello John Officer: See Remarks
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (20,000) — exercise price 14.56
Disposed (D)20,000——0Direct (D) No
F1, F4
  • F1 On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026.
  • F4 This option represents a right to purchase a total of 20,000 shares of the Issuer's Common Stock, 6,672 of which will become fully vested and exercisable on January 28, 2020, with the remaining 13,328 shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.
Open filing 0001140361-26-023153 Read from the filing’s XML Dispute this row
2026-05-26 Filed 2026-05-28Militello John Officer: See Remarks
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (10,000) — exercise price 10.85
Disposed (D)10,000——0Direct (D) No
F1, F5
  • F1 On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026.
  • F5 This option represents a right to purchase a total of 10,000 shares of the Issuer's Common Stock, 3,336 of which will become fully vested and exercisable on September 2, 2020, with the remaining 6,664 shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.
Open filing 0001140361-26-023153 Read from the filing’s XML Dispute this row
2026-05-26 Filed 2026-05-28Militello John Officer: See Remarks
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (20,000) — exercise price 22.72
Disposed (D)20,000——0Direct (D) No
F1, F6
  • F1 On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026.
  • F6 This option represents a right to purchase a total of 20,000 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 6, 2021, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.
Open filing 0001140361-26-023153 Read from the filing’s XML Dispute this row
2026-05-26 Filed 2026-05-28Militello John Officer: See Remarks
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (2,000) — exercise price 23.89
Disposed (D)2,000——0Direct (D) No
F1, F7
  • F1 On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026.
  • F7 This option represents a right to purchase a total of 2,000 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 10, 2021, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.
Open filing 0001140361-26-023153 Read from the filing’s XML Dispute this row
2026-05-26 Filed 2026-05-28Militello John Officer: See Remarks
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (18,000) — exercise price 24.82
Disposed (D)18,000——0Direct (D) No
F1, F8
  • F1 On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026.
  • F8 This option represents a right to purchase a total of 18,000 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on August 3, 2021, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.
Open filing 0001140361-26-023153 Read from the filing’s XML Dispute this row
2026-05-26 Filed 2026-05-28Militello John Officer: See Remarks
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (18,000) — exercise price 62.32
Disposed (D)18,000——0Direct (D) No
F1, F9
  • F1 On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026.
  • F9 The option represents a right to purchase a total of 18,000 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 4, 2022, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.
Open filing 0001140361-26-023153 Read from the filing’s XML Dispute this row
2026-05-26 Filed 2026-05-28Militello John Officer: See Remarks
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (27,003) — exercise price 19.05
Disposed (D)27,003——0Direct (D) No
F1, F10
  • F1 On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026.
  • F10 This option represents a right to purchase a total of 27,003 shares of the Issuer's common stock, one-third of which will become fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.
Open filing 0001140361-26-023153 Read from the filing’s XML Dispute this row
2026-05-26 Filed 2026-05-28Militello John Officer: See Remarks
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (28,910) — exercise price 13.12
Disposed (D)28,910——0Direct (D) No
F1, F11
  • F1 On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026.
  • F11 This option represents a right to purchase a total of 28,910 shares of the Issuer's common stock, one-third of which will become fully vested and exercisable on April 18, 2023, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.
Open filing 0001140361-26-023153 Read from the filing’s XML Dispute this row
2026-05-26 Filed 2026-05-28Militello John Officer: See Remarks
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (49,798) — exercise price 20.04
Disposed (D)49,798——0Direct (D) No
F1, F12
  • F1 On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026.
  • F12 This option represents a right to purchase a total of 49,798 shares of the Issuer's common stock, one-third of which will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.
Open filing 0001140361-26-023153 Read from the filing’s XML Dispute this row
2026-05-26 Filed 2026-05-28Militello John Officer: See Remarks
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (24,545) — exercise price 30.01
Disposed (D)24,545——0Direct (D) No
F1, F13
  • F1 On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026.
  • F13 This option represents a right to purchase a total of 24,545 shares of the Issuer's common stock, one-third of which will become fully vested and exercisable on February 16, 2026, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.
Open filing 0001140361-26-023153 Read from the filing’s XML Dispute this row
2026-05-26 Filed 2026-05-28Militello John Officer: See Remarks
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (51,509) — exercise price 3
Acquired (A)51,509——51,509Direct (D) No
F1, F14
  • F1 On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026.
  • F14 Represents a right to purchase shares of the Issuer's common stock, which will become fully vested on May 26, 2027, subject to the reporting person's continued employment with the Issuer.
Open filing 0001140361-26-023153 Read from the filing’s XML Dispute this row
2026-05-26 Filed 2026-05-28Militello John Officer: See Remarks
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (15,002) — exercise price 3
Acquired (A)15,002——15,002Direct (D) No
F1, F14
  • F1 On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026.
  • F14 Represents a right to purchase shares of the Issuer's common stock, which will become fully vested on May 26, 2027, subject to the reporting person's continued employment with the Issuer.
Open filing 0001140361-26-023153 Read from the filing’s XML Dispute this row
2026-05-26 Filed 2026-05-28Militello John Officer: See Remarks
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (16,061) — exercise price 3
Acquired (A)16,061——16,061Direct (D) No
F1, F14
  • F1 On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026.
  • F14 Represents a right to purchase shares of the Issuer's common stock, which will become fully vested on May 26, 2027, subject to the reporting person's continued employment with the Issuer.
Open filing 0001140361-26-023153 Read from the filing’s XML Dispute this row
2026-05-26 Filed 2026-05-28Militello John Officer: See Remarks
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (24,899) — exercise price 3
Acquired (A)24,899——24,899Direct (D) No
F1, F14
  • F1 On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026.
  • F14 Represents a right to purchase shares of the Issuer's common stock, which will become fully vested on May 26, 2027, subject to the reporting person's continued employment with the Issuer.
Open filing 0001140361-26-023153 Read from the filing’s XML Dispute this row
2026-05-26 Filed 2026-05-28Militello John Officer: See Remarks
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (9,091) — exercise price 3
Acquired (A)9,091——9,091Direct (D) No
F1, F15
  • F1 On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026.
  • F15 This option represents a right to purchase a total of 9,091 shares of the Issuer's common stock, one-half of which will become fully vested and exercisable on May 26, 2027, with the remaining shares becoming fully vested and exercisable on May 26, 2028, in each case, subject to the reporting person's continued employment with the Issuer.
Open filing 0001140361-26-023153 Read from the filing’s XML Dispute this row
2026-05-21 Filed 2026-05-26Shah Gaurav Officer: CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)76,4901.691
129,344.59

Derived: shares × price per share. Exact value 129344.590.

1,117,408Direct (D) No
F1, F2
  • F1 Holdings include Restricted Stock Units that convert to common stock on a one-for-one basis.
  • F2 Represents shares received upon exercise of a Stock Option in advance of the expiration of such Stock Option.
Open filing 0001140361-26-022894 Read from the filing’s XML Dispute this row
2026-05-21 Filed 2026-05-26Shah Gaurav Officer: CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)55,6843.086
171,840.824

Derived: shares × price per share. Exact value 171840.824.

1,061,724Direct (D) No
F1, F3, F4
  • F1 Holdings include Restricted Stock Units that convert to common stock on a one-for-one basis.
  • F3 Represents shares sold by the Reporting Person in order to pay the exercise price of a Stock Option and to cover certain taxes in connection with the exercise of the Stock Option.
  • F4 Represents a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $3.08 to $3.105. The Reporting Person has provided the issuer and will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Open filing 0001140361-26-022894 Read from the filing’s XML Dispute this row
2026-05-21 Filed 2026-05-26Shah Gaurav Officer: CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (76,490) — exercise price 1.691
Disposed (D)76,4901.691
129,344.59

Derived: shares × price per share. Exact value 129344.590.

0Direct (D) No
F5
  • F5 This option represents a right to purchase a total of 76,490 shares of the Issuer's Common Stock, one-third of which became fully vested and exercisable on April 12, 2018, with the remaining two-thirds vesting in equal quarterly installments over the following two years.
Open filing 0001140361-26-022894 Read from the filing’s XML Dispute this row
2026-05-19 Filed 2026-05-21Wilson Martin Officer: General Counsel
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)6623.014
1,995.268

Derived: shares × price per share. Exact value 1995.268.

677,977Direct (D) No
F1, F2
  • F1 Holdings include Restricted Stock Units (RSUs) that convert to common stock on a one-for-one basis.
  • F2 The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
Open filing 0001140361-26-022446 Read from the filing’s XML Dispute this row
2026-05-19 Filed 2026-05-21Shah Gaurav Officer: CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,4093.014
7,260.726

Derived: shares × price per share. Exact value 7260.726.

1,040,918Direct (D) No
F1, F2
  • F1 Holdings include Restricted Stock Units (RSUs) that convert to common stock on a one-for-one basis.
  • F2 The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
Open filing 0001140361-26-022447 Read from the filing’s XML Dispute this row

Latest reported holdings

What each reporting owner last said they hold, as of the date shown. A transaction not yet filed is not in it.

Latest reported holdings
Reporting ownerSecurityShares owned afterDirect or indirectSource
BOESS CARSTEN DirectorStock Option (Right to Buy) Derivative security · underlying Common Stock64,860D As of 2026-06-18 Open filing 4
BOESS CARSTEN DirectorCommon Stock 52,862D As of 2026-06-18 Open filing 4
Bjork Elisabeth DirectorCommon Stock 50,000D As of 2026-01-02 Open filing 4
Chaudhuri Sarbani Officer: See RemarksStock Option (Right to Buy) Derivative security · underlying Common Stock189,076D As of 2026-02-11 Open filing 4
Chaudhuri Sarbani Officer: See RemarksCommon Stock 257,937D As of 2026-11-09 Open filing 4
Dolsten Mikael DirectorStock Option (Right to Buy) Derivative security · underlying Common Stock64,860D As of 2026-06-18 Open filing 4
Dolsten Mikael DirectorCommon Stock 67,082D As of 2026-06-18 Open filing 4
Fong Peter DirectorStock Option (Right to Buy) Derivative security · underlying Common Stock64,860D As of 2026-06-18 Open filing 4
Fong Peter DirectorCommon Stock 76,195D As of 2026-06-18 Open filing 4
GRANADILLO PEDRO P DirectorCommon Stock 54,734D As of 2025-06-18 Open filing 4
Makker Gotham DirectorCommon Stock 621,500I By Non-Revocable TrustAs of 2025-07-18 Open filing 4
Makker Gotham DirectorCommon Stock 415,346I By Simran Investment GroupAs of 2025-06-18 Open filing 4
Malik Fady Ibraham DirectorStock Option (Right to Buy) Derivative security · underlying Common Stock64,860D As of 2026-06-18 Open filing 4
Malik Fady Ibraham DirectorCommon Stock 52,862D As of 2026-06-18 Open filing 4
Manhede Joseph Officer: Principal Accounting OfficerCommon Stock 52,576D As of 2026-07-08 Open filing 3
Militello John Officer: See RemarksStock Option (Right to Buy) Derivative security · underlying Common Stock9,091D As of 2026-05-26 Open filing 4
Militello John Officer: See RemarksCommon Stock 89,780D As of 2026-05-19 Open filing 4
Ondrey Aaron Officer: Chief Financial OfficerStock Option (Right to Buy) Derivative security · underlying Common Stock134,642D As of 2025-02-11 Open filing 4
Ondrey Aaron Officer: Chief Financial OfficerCommon Stock 128,173D As of 2025-07-03 Open filing 4
Patel Kinnari Officer: See RemarksStock Option (Right to Buy) Derivative security · underlying Common Stock172,214D As of 2025-02-11 Open filing 4
Patel Kinnari Officer: See RemarksCommon Stock 444,103D As of 2025-04-10 Open filing 4
Patel Kinnari Officer: See RemarksCommon Stock 104,927I By Adaptive Technology LLCAs of 2025-05-22 Open filing 4
Patel Kinnari Officer: See RemarksCommon Stock 26,774I By SpouseAs of 2025-05-22 Open filing 4
Patel Kinnari Officer: See RemarksCommon Stock 441,927D As of 2025-05-20 Open filing 4
Patel Kinnari Officer: See RemarksCommon Stock 26,774I By SpouseAs of 2025-04-09 Open filing 4
Pratumsuwan Piratip DirectorStock Option (Right to Buy) Derivative security · underlying Common Stock22,443D As of 2025-02-03 Open filing 4
Pratumsuwan Piratip DirectorCommon Stock 30,000D As of 2025-06-18 Open filing 4
RTW INVESTMENTS, LP Director · 10% owner · Other: See remarksEquity Swap (obligation to buy) Derivative security · underlying Common Stock0I See footnoteAs of 2025-09-19 Open filing 4
RTW INVESTMENTS, LP Director · 10% owner · Other: See remarksPre-funded Warrant (right to buy) Derivative security · underlying Common Stock3,526,955I See footnoteAs of 2024-12-12 Open filing 4
RTW INVESTMENTS, LP Director · 10% owner · Other: See remarksCommon Stock 47,667D As of 2025-09-23 Open filing 4
RTW INVESTMENTS, LP Director · 10% owner · Other: See remarksCommon Stock 18,188,457I See footnoteAs of 2025-09-19 Open filing 4
Rizvi Syed Ali-aamir Officer: Chief Medical OfficerStock Option (right to buy) Derivative security · underlying Common Stock93,037D As of 2026-02-11 Open filing 4
Rizvi Syed Ali-aamir Officer: Chief Medical OfficerCommon Stock 407,874D As of 2026-02-11 Open filing 4
SOUTHWELL DAVID P DirectorStock Option (Right to Buy) Derivative security · underlying Common Stock64,860D As of 2026-06-18 Open filing 4
SOUTHWELL DAVID P DirectorCommon Stock 113,124I By The David P. Southwell Irrevocable Trust Dtd 04/14/2024As of 2026-08-05 Open filing 4
SOUTHWELL DAVID P DirectorCommon Stock 204,522D As of 2026-08-03 Open filing 4
Schwartz Jonathan David Officer: See RemarksStock Option (Right to Buy) Derivative security · underlying Common Stock119,682D As of 2025-02-11 Open filing 4
Schwartz Jonathan David Officer: See RemarksCommon Stock 299,064D As of 2025-11-18 Open filing 4
Shah Gaurav Officer: CEOStock Option (Right to Buy) Derivative security · underlying Common Stock0D As of 2026-05-21 Open filing 4
Shah Gaurav Officer: CEOCommon Stock 198,341I By Gaurav D. Shah Irrevocable TrustAs of 2026-11-20 Open filing 4
Shah Gaurav Officer: CEOCommon Stock 207,897I By SpouseAs of 2026-11-20 Open filing 4
Shah Gaurav Officer: CEOCommon Stock 1,051,358D As of 2026-11-18 Open filing 4
Stevens Christopher James Officer: Chief Operating OfficerStock Option (Right to Buy) Derivative security · underlying Common Stock101,428D As of 2026-08-03 Open filing 4
Stevens Christopher James Officer: Chief Operating OfficerCommon Stock 505,784D As of 2026-08-11 Open filing 4
WONG RODERICK Director · 10% owner · Other: See RemarksEquity Swap (obligation to buy) Derivative security · underlying Common Stock0I See footnoteAs of 2025-09-19 Open filing 4
WONG RODERICK Director · 10% owner · Other: See remarksPre-funded Warrant (right to buy) Derivative security · underlying Common Stock3,526,955I See footnoteAs of 2024-12-12 Open filing 4
WONG RODERICK Director · 10% ownerStock Option (Right to Buy) Derivative security · underlying Common Stock78,960D As of 2026-06-18 Open filing 4
WONG RODERICK Director · 10% owner · Other: See RemarksCommon Stock 47,667D As of 2025-09-23 Open filing 4
WONG RODERICK Director · 10% ownerCommon Stock 18,188,457I See footnoteAs of 2026-07-06 Open filing 4
WONG RODERICK Director · 10% ownerCommon Stock 75,499D As of 2026-06-18 Open filing 4
WONG RODERICK Director · 10% owner · Other: See RemarksCommon Stock 18,188,457I See footnoteAs of 2025-09-19 Open filing 4
Wilson Martin Officer: General CounselStock Option (Right to Buy) Derivative security · underlying Common Stock468,187D As of 2026-02-11 Open filing 4
Wilson Martin Officer: General CounselCommon Stock 540,336D As of 2026-11-18 Open filing 4

Joint filers each report the same shares, so rows are not added together.

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.

Showing 1–50 of 181

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
RTW INVESTMENTS, LP 17,687,772 SH46,518,840 dollarsLower by 350,000 Prior quarter: 18,037,772Open filing 0001493215-26-000214 Filed 2026-11-16 Dispute this row
BlackRock, Inc. Partly reported under another manager13,168,218 SH34,632,415 dollarsHigher by 3,244,256 Prior quarter: 9,923,962Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
MILLENNIUM MANAGEMENT LLC 4,820,893 SH12,678,949 dollarsHigher by 820,549 Prior quarter: 4,000,344Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row
CITIGROUP INC Partly reported under another manager4,609,231 SH12,122,277 dollarsLower by 256,320 Prior quarter: 4,865,551Open filing 0000831001-26-000052 Filed 2026-11-04 Dispute this row
Newtyn Management, LLC 4,000,000 SH10,520,000 dollarsUnchanged Prior quarter: 4,000,000Open filing 0001493152-26-052329 Filed 2026-11-16 Dispute this row
MAVERICK CAPITAL LTD 3,839,663 SH10,098,314 dollarsLower by 84,300 Prior quarter: 3,923,963Open filing 0000947871-26-001025 Filed 2026-11-16 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 3,830,455 SH10,074,097 dollarsHigher by 46,068 Prior quarter: 3,784,387Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
MARSHALL WACE, LLP Partly reported under another manager3,513,704 SH9,241,041 dollarsLower by 515,558 Prior quarter: 4,029,262Open filing 0001318757-26-000012 Filed 2026-11-13 Dispute this row
Monaco Asset Management SAM Partly reported under another manager2,920,490 SH7,680,889 dollarsHigher by 440,022 Prior quarter: 2,480,468Open filing 0001803593-26-000014 Filed 2026-11-09 Dispute this row
FEDERATED HERMES, INC. Partly reported under another manager2,528,253 SH6,649,306 dollarsHigher by 224,046 Prior quarter: 2,304,207Open filing 0001623632-26-001675 Filed 2026-11-12 Dispute this row
Rosalind Advisors, Inc. 2,200,000 SH5,786,000 dollarsNot in the prior quarter’s filings read Open filing 0001622627-26-000034 Filed 2026-11-16 Dispute this row
STATE STREET CORP Partly reported under another manager1,879,309 SH4,942,583 dollarsHigher by 59,188 Prior quarter: 1,820,121Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager1,829,380 SH4,811,270 dollarsLower by 1,004,047 Prior quarter: 2,833,427Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager1,716,748 SH4,516,497 dollarsLower by 653,981 Prior quarter: 2,370,729Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
AQR CAPITAL MANAGEMENT LLC Partly reported under another manager1,675,732 SH4,407,176 dollarsLower by 1,710,430 Prior quarter: 3,386,162Open filing 0001167557-26-000324 Filed 2026-11-16 Dispute this row
MORGAN STANLEY Partly reported under another manager1,497,027 SH3,937,183 dollarsHigher by 434,505 Prior quarter: 1,062,522Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 1,426,326 SH3,751,237 dollarsLower by 4,383,707 Prior quarter: 5,810,033Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
DIMENSIONAL FUND ADVISORS LP Partly reported under another manager1,346,107 SH3,539,913 dollarsHigher by 220,607 Prior quarter: 1,125,500Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row
Aberdeen Group plc Partly reported under another manager1,168,417 SH3,072,937 dollarsHigher by 770,690 Prior quarter: 397,727Open filing 0001716774-26-000032 Filed 2026-11-10 Dispute this row
JACOBS LEVY EQUITY MANAGEMENT, INC 1,157,382 SH3,043,915 dollarsLower by 817,514 Prior quarter: 1,974,896Open filing 0000884414-26-000004 Filed 2026-11-16 Dispute this row
FMR LLC Partly reported under another manager1,028,743 SH2,705,593 dollarsHigher by 540,444 Prior quarter: 488,299Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
Opaleye Management Inc. 1,000,000 SH2,630,000 dollarsUnchanged Prior quarter: 1,000,000Open filing 0001420506-26-002880 Filed 2026-11-16 Dispute this row
RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager928,731 SH2,442,563 dollarsHigher by 135,757 Prior quarter: 792,974Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row
D. E. Shaw Co., Inc. Partly reported under another manager806,281 SH2,120,519 dollarsLower by 144,271 Prior quarter: 950,552Open filing 0001104659-26-128287 Filed 2026-11-16 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 776,010 SH2,040,906 dollarsHigher by 26,937 Prior quarter: 749,073Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager763,415 SH1,977,245 dollarsLower by 1,224,998 Prior quarter: 1,988,413Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
BANK OF AMERICA CORP /DE/ Partly reported under another manager743,717 SH1,955,976 dollarsHigher by 9,133 Prior quarter: 734,584Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager720,007 SH1,893,619 dollarsLower by 15,083 Prior quarter: 735,090Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
Woodline Partners LP 641,222 SH1,686,414 dollarsUnchanged Prior quarter: 641,222Open filing 0001172661-26-005063 Filed 2026-11-16 Dispute this row
Prosight Management, LP 595,024 SH1,564,913 dollarsLower by 104,976 Prior quarter: 700,000Open filing 0001420506-26-002713 Filed 2026-11-13 Dispute this row
VANGUARD FIDUCIARY TRUST CO 592,687 SH1,558,767 dollarsLower by 157 Prior quarter: 592,844Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
Point72 Asset Management, L.P. 516,662 SH1,358,821 dollarsLower by 153,865 Prior quarter: 670,527Open filing 0000919574-26-008126 Filed 2026-11-16 Dispute this row
BNP PARIBAS FINANCIAL MARKETS Partly reported under another manager450,409 SH1,184,576 dollarsHigher by 63,344 Prior quarter: 387,065Open filing 0001166588-26-000012 Filed 2026-11-12 Dispute this row
ADAR1 Capital Management, LLC 442,500 SH1,163,775 dollarsHigher by 7,000 Prior quarter: 435,500Open filing 0001940272-26-000033 Filed 2026-11-16 Dispute this row
Jump Financial, LLC Partly reported under another manager421,409 SH1,108,306 dollarsLower by 446,491 Prior quarter: 867,900Open filing 0000905148-26-004786 Filed 2026-11-13 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager365,695 SH961,778 dollarsLower by 15,845 Prior quarter: 381,540Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
Susquehanna Portfolio Strategies, LLC 339,996 SH894,189 dollarsHigher by 7,890 Prior quarter: 332,106Open filing 0001996449-26-000009 Filed 2026-11-16 Dispute this row
Invesco Ltd. Partly reported under another manager338,078 SH889,145 dollarsLower by 45,238 Prior quarter: 383,316Open filing 0000914208-26-000462 Filed 2026-11-12 Dispute this row
Man Group plc Partly reported under another manager334,626 SH880,066 dollarsNot in the prior quarter’s filings read Open filing 0001637460-26-000004 Filed 2026-11-16 Dispute this row
LPL Financial LLC 322,772 SH848,890 dollarsHigher by 936 Prior quarter: 321,836Open filing 0001403438-26-000005 Filed 2026-11-06 Dispute this row
WELLINGTON MANAGEMENT GROUP LLP Partly reported under another manager319,311 SH839,788 dollarsHigher by 257,706 Prior quarter: 61,605Open filing 0000902219-26-000323 Filed 2026-11-16 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Option: Call Partly reported under another manager283,500 SH745,605 dollarsHigher by 104,300 Prior quarter: 179,200Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager256,634 SH674,948 dollarsLower by 3,175 Prior quarter: 259,809Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
TWO SIGMA INVESTMENTS, LP 256,231 SH673,888 dollarsLower by 59,530 Prior quarter: 315,761Open filing 0000899140-26-001341 Filed 2026-11-16 Dispute this row
AMERIPRISE FINANCIAL INC Partly reported under another manager247,113 SH649,907 dollarsLower by 27,896 Prior quarter: 275,009Open filing 0001193125-26-463125 Filed 2026-11-16 Dispute this row
Privium Fund Management B.V. 244,146 SH642,104 dollarsUnchanged Prior quarter: 244,146Open filing 0001754960-26-000972 Filed 2026-11-03 Dispute this row
AMERICAN CENTURY COMPANIES INC Partly reported under another manager229,458 SH603,474 dollarsHigher by 127,844 Prior quarter: 101,614Open filing 0000748054-26-000009 Filed 2026-11-20 Dispute this row
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Partly reported under another manager224,096 SH589,373 dollarsHigher by 71,465 Prior quarter: 152,631Open filing 0000905148-26-004850 Filed 2026-11-16 Dispute this row
UBS Group AG Partly reported under another manager221,518 SH582,591 dollarsHigher by 19,876 Prior quarter: 201,642Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
Hennion Walsh Asset Management, Inc. 220,426 SH579,720 dollarsLower by 4,501 Prior quarter: 224,927Open filing 0002000324-26-005579 Filed 2026-10-13 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Sixth Street Partners Management Company, L.P. 749,073 SH
  • Qube Research Technologies Ltd 644,869 SH
  • Sio Capital Management, LLC 400,000 SH
  • Walleye Capital LLC 344,756 SH
  • BIT Capital GmbH 298,000 SH
  • GOLDMAN SACHS GROUP INC 140,000 SH
  • Schonfeld Strategic Advisors LLC 110,666 SH
  • SILVERARC CAPITAL MANAGEMENT, LLC 104,828 SH
  • Weiss Asset Management LP 86,064 SH
  • LMR Partners LLP 75,731 SH
  • Affinity Asset Advisors, LLC 75,000 SH
  • Marex Group Ltd 72,500 SH
  • Corient Private Wealth LP 37,819 SH
  • Values First Advisors, Inc. 37,446 SH
  • Dynamic Technology Lab Private Ltd 23,398 SH
  • INTECH INVESTMENT MANAGEMENT LLC 23,123 SH
  • Merit Financial Group, LLC 19,360 SH
  • SG Americas Securities, LLC 18,819 SH
  • MAI Capital Management 18,685 SH
  • ExodusPoint Capital Management, LP 18,635 SH
  • Integrated Wealth Concepts LLC 16,742 SH
  • Krilogy Financial LLC 14,295 SH
  • Pallas Capital Advisors LLC 13,721 SH
  • Virtu Financial LLC 11,562 SH
  • a16z Perennial Management, L.P. 11,335 SH
  • HB Wealth Management, LLC 10,541 SH
  • XTX Topco Ltd 10,288 SH
  • FRANKLIN RESOURCES INC 10,166 SH
  • Wealth Enhancement Trust Services, Inc. 459 SH
  • ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ 202 SH
  • Basecamp Wealth Advisors LLC 141 SH
  • Clearstead Advisors, LLC 122 SH
  • MassMutual Private Wealth Trust, FSB 114 SH
  • Clear Street Group Inc. 99 SH
  • TORONTO DOMINION BANK 99 SH
  • GILL CAPITAL PARTNERS, LLC 4 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text; they are read only when their rows add up to the totals the filer states.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Institutional ownership reported on Form 13F

13F filers report holding between 36.67% and 86.62% of shares outstanding.

Quarter ending 2026-09-30, against 111,660,283 shares on the cover dated 2026-11-06.

  • The lower figure counts positions a manager reports as its own with sole discretion. The upper figure counts every plain-share position and can count a share twice.
  • Neither includes holders that do not file Form 13F, or managers below the filing threshold.
Quarter-by-quarter 13F holders
QuarterManagers holdingShares, at leastShares, at mostFilings read
2026-09-30 17540,946,94496,715,8168,935
2026-06-30 19042,556,240102,187,5279,178
2026-03-31 20738,337,95498,843,0899,173
2025-12-31 19543,141,69493,042,4369,222
2025-09-30 18255,461,008100,858,8988,469
2025-06-30 20755,970,92497,637,0588,516
2025-03-31 24851,323,292110,088,4418,518
2024-12-31 23449,030,744111,812,7188,580

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

Showing 1–2 of 2

House members’ trades in this company, newest report first, as filed
MemberTransaction dateTypeAmountOwnerReport
Hon. Roger W. Marshall (KS01)2017-09-13Purchase$1,001 - $15,000DC2018-08-06
Hon. Roger W. Marshall (KS01)2017-09-13Sale$1,001 - $15,000DC2018-08-06

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read from their tags. Earlier schedules are free text: they are read only when every cover page states a share count and a percent, and the rest are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Vanguard Portfolio Management Common Stock1.331,463,67709/30/2026 Filed 2026-10-30SCHEDULE 13G/AAmendment 1Open filing 0002100121-26-001123 Dispute this row
Vanguard Portfolio Management Common Stock5.355,847,54106/30/2026 Filed 2026-07-31SCHEDULE 13GOpen filing 0002100121-26-001008 Dispute this row
The Vanguard Group Common Stock0003/13/2026 Filed 2026-03-27SCHEDULE 13G/AAmendment 4Open filing 0000102909-26-002213 Dispute this row
Maverick Capital, Ltd. Common stock, $0.01 par value per share2.32,513,11012/31/2025 Filed 2026-02-13SCHEDULE 13G/AAmendment 2Open filing 0001012975-26-000137 Dispute this row
Maverick Capital Management, LLC Common stock, $0.01 par value per share2.32,513,11012/31/2025 Filed 2026-02-13SCHEDULE 13G/AAmendment 2Open filing 0001012975-26-000137 Dispute this row
Lee S. Ainslie III Common stock, $0.01 par value per share2.32,513,11012/31/2025 Filed 2026-02-13SCHEDULE 13G/AAmendment 2Open filing 0001012975-26-000137 Dispute this row
The Vanguard Group Common Stock7.898,544,42312/31/2025 Filed 2026-01-30SCHEDULE 13G/AAmendment 3Open filing 0000102909-26-000302 Dispute this row
Maverick Capital, Ltd. Common Stock, $0.01 par value per share7.88,363,813.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0001641172-25-023726 Dispute this row
Maverick Capital Management, LLC Common Stock, $0.01 par value per share7.88,363,813.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0001641172-25-023726 Dispute this row
Lee S. Ainslie III Common Stock, $0.01 par value per share7.88,363,813.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0001641172-25-023726 Dispute this row
Wellington Management Group LLP Common Stock12.3611,242,144— Filed 2024-11-08SC 13G/AAmendment 2Read from the cover page textOpen filing 0000902219-24-000478 Dispute this row
Wellington Group Holdings LLP Common Stock12.3611,242,144— Filed 2024-11-08SC 13G/AAmendment 2Read from the cover page textOpen filing 0000902219-24-000478 Dispute this row
Wellington Investment Advisors Holdings LLP Common Stock12.3611,242,144— Filed 2024-11-08SC 13G/AAmendment 2Read from the cover page textOpen filing 0000902219-24-000478 Dispute this row
Wellington Management Company LLP Common Stock11.9210,843,072— Filed 2024-11-08SC 13G/AAmendment 2Read from the cover page textOpen filing 0000902219-24-000478 Dispute this row
Wellington Management Group LLP Common Stock10.129,156,099— Filed 2024-04-05SC 13G/AAmendment 1Read from the cover page textOpen filing 0000902219-24-000295 Dispute this row
Wellington Group Holdings LLP Common Stock10.129,156,099— Filed 2024-04-05SC 13G/AAmendment 1Read from the cover page textOpen filing 0000902219-24-000295 Dispute this row
Wellington Investment Advisors Holdings LLP Common Stock10.129,156,099— Filed 2024-04-05SC 13G/AAmendment 1Read from the cover page textOpen filing 0000902219-24-000295 Dispute this row
Wellington Management Company LLP Common Stock9.768,836,742— Filed 2024-04-05SC 13G/AAmendment 1Read from the cover page textOpen filing 0000902219-24-000295 Dispute this row
The Vanguard Group - 23-1945930 Name of issuer: Rocket Pharmaceuticals Inc6.045,447,565— Filed 2024-02-13SC 13G/AAmendment 2Read from the cover page textOpen filing 0001104659-24-021855 Dispute this row
Wellington Management Group LLP Common Stock9.098,197,546— Filed 2024-02-08SC 13GRead from the cover page textOpen filing 0000902219-24-000121 Dispute this row
Wellington Group Holdings LLP Common Stock9.098,197,546— Filed 2024-02-08SC 13GRead from the cover page textOpen filing 0000902219-24-000121 Dispute this row
Wellington Investment Advisors Holdings LLP Common Stock9.098,197,546— Filed 2024-02-08SC 13GRead from the cover page textOpen filing 0000902219-24-000121 Dispute this row
Wellington Management Company LLP Common Stock8.747,876,583— Filed 2024-02-08SC 13GRead from the cover page textOpen filing 0000902219-24-000121 Dispute this row
BlackRock, Inc. Common Stock6.65,930,178— Filed 2024-01-29SC 13G/AAmendment 2Read from the cover page textOpen filing 0001086364-24-005099 Dispute this row
The Vanguard Group - 23-1945930 Name of issuer: Rocket Pharmaceuticals Inc.5.324,186,542— Filed 2023-02-09SC 13G/AAmendment 1Read from the cover page textOpen filing 0001104659-23-016868 Dispute this row
Wellington Management Group LLP Common Stock4.453,507,017— Filed 2023-02-06SC 13G/AAmendment 1Read from the cover page textOpen filing 0000846087-23-000167 Dispute this row
Wellington Group Holdings LLP Common Stock4.453,507,017— Filed 2023-02-06SC 13G/AAmendment 1Read from the cover page textOpen filing 0000846087-23-000167 Dispute this row
Wellington Investment Advisors Holdings LLP Common Stock4.453,507,017— Filed 2023-02-06SC 13G/AAmendment 1Read from the cover page textOpen filing 0000846087-23-000167 Dispute this row
BlackRock, Inc. Common Stock7.15,587,535— Filed 2023-01-31SC 13G/AAmendment 1Read from the cover page textOpen filing 0001306550-23-005154 Dispute this row
RTW Investments, LP Common Stock, par value $0.01 per share24.317,628,567— Filed 2022-10-11SC 13D/AAmendment 8Read from the cover page textOpen filing 0000902664-22-004506 Dispute this row
Roderick Wong Common Stock, par value $0.01 per share24.417,628,567— Filed 2022-10-11SC 13D/AAmendment 8Read from the cover page textOpen filing 0000902664-22-004506 Dispute this row
RTW Investments, LP Common Stock, par value $0.01 per share24.616,272,635— Filed 2022-09-21SC 13D/AAmendment 7Read from the cover page textOpen filing 0000902664-22-004312 Dispute this row
Roderick Wong Common Stock, par value $0.01 per share24.616,272,635— Filed 2022-09-21SC 13D/AAmendment 7Read from the cover page textOpen filing 0000902664-22-004312 Dispute this row
TANG CAPITAL PARTNERS, LP Common Stock, par value $0.01 per share3.92,531,800— Filed 2022-02-14SC 13G/AAmendment 2Read from the cover page textOpen filing 0001214659-22-002551 Dispute this row
TANG CAPITAL MANAGEMENT, LLC Common Stock, par value $0.01 per share3.92,531,800— Filed 2022-02-14SC 13G/AAmendment 2Read from the cover page textOpen filing 0001214659-22-002551 Dispute this row
KEVIN TANG Common Stock, par value $0.01 per share3.92,531,800— Filed 2022-02-14SC 13G/AAmendment 2Read from the cover page textOpen filing 0001214659-22-002551 Dispute this row
Perceptive Advisors LLC Common Stock, $0.01 par value per share3.01,959,125— Filed 2022-02-14SC 13G/AAmendment 1Read from the cover page textOpen filing 0001193125-22-042224 Dispute this row
Joseph Edelman Common Stock, $0.01 par value per share3.01,959,125— Filed 2022-02-14SC 13G/AAmendment 1Read from the cover page textOpen filing 0001193125-22-042224 Dispute this row
Perceptive Life Sciences Master Fund, Ltd. Common Stock, $0.01 par value per share3.01,959,125— Filed 2022-02-14SC 13G/AAmendment 1Read from the cover page textOpen filing 0001193125-22-042224 Dispute this row
T. ROWE PRICE ASSOCIATES, INC. COMMON STOCK3.42,192,894— Filed 2022-02-14SC 13G/AAmendment 1Read from the cover page textOpen filing 0000080255-22-002124 Dispute this row
The Vanguard Group - 23-1945930 Name of issuer: Rocket Pharmaceuticals Inc.5.123,301,138— Filed 2022-02-10SC 13GRead from the cover page textOpen filing 0001104659-22-018476 Dispute this row
Wellington Management Group LLP Common Stock5.423,490,879— Filed 2022-02-04SC 13GRead from the cover page textOpen filing 0001678858-22-000220 Dispute this row
Wellington Group Holdings LLP Common Stock5.423,490,879— Filed 2022-02-04SC 13GRead from the cover page textOpen filing 0001678858-22-000220 Dispute this row
Wellington Investment Advisors Holdings LLP Common Stock5.423,490,879— Filed 2022-02-04SC 13GRead from the cover page textOpen filing 0001678858-22-000220 Dispute this row
Wellington Management Company LLP Common Stock5.153,316,746— Filed 2022-02-04SC 13GRead from the cover page textOpen filing 0001678858-22-000220 Dispute this row
BlackRock, Inc. Common Stock5.23,339,469— Filed 2022-02-04SC 13GRead from the cover page textOpen filing 0000834237-22-007126 Dispute this row
RTW Investments, LP COMMON STOCK25.316,272,635— Filed 2021-08-31SC 13D/AAmendment 6Read from the cover page textOpen filing 0001193125-21-262169 Dispute this row
Roderick Wong COMMON STOCK25.316,272,635— Filed 2021-08-31SC 13D/AAmendment 6Read from the cover page textOpen filing 0001193125-21-262169 Dispute this row
RTW Investments, LP COMMON STOCK26.216,185,119— Filed 2021-03-29SC 13D/AAmendment 5Read from the cover page textOpen filing 0001493152-21-007090 Dispute this row
Roderick Wong COMMON STOCK26.216,185,119— Filed 2021-03-29SC 13D/AAmendment 5Read from the cover page textOpen filing 0001493152-21-007090 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

3,092,627 filings read, dated 1980-01-02 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015246,723
2016246,472
2017244,814
2018245,575
2019238,619
2020249,093
2021274,850
2022257,922
2023253,676
2024261,106
2025235,525
2026263,830

Filings made before the SEC required XML are listed, not extracted.

Back to Rocket Pharmaceuticals, Inc.